|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
ensuring medicines and medical devices work and are acceptably safe
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
post-market surveillance
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
monitoring of product safety
|
|
gptkb:CIMA_(Cayman_Islands)
|
enforcement of financial laws
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
enforcing regulations
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
public health protection
|
|
gptkb:GAL3
|
positive regulator
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
recall of unsafe products
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
medical device registration
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
inspection and enforcement
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
inspecting manufacturers and distributors
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
pharmacovigilance
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
medical device safety
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
adverse event reporting
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
public health protection
|
|
gptkb:CIMA_(Cayman_Islands)
|
market conduct supervision
|
|
gptkb:CIMA_(Cayman_Islands)
|
prudential supervision
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
clinical trial authorisation
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
licensing medicines
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
clinical trial approval
|